Drug Profile
Research programme: proteasome inhibitors - Telik
Latest Information Update: 11 Oct 2010
Price :
$50
*
At a glance
- Originator Telik
- Class Small molecules
- Mechanism of Action Apoptosis stimulants; Proteasome inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 03 Mar 2008 Preclinical trials in Cancer in USA (PO)